Goldman Sachs’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $65.3M | Buy |
|
|||||
|
2022
Q3 | $8.82M | Buy |
|
|||||
|
2022
Q2 | $5.2M | Buy |
|
|||||
|
2022
Q1 | $2.8M | Buy |
|
|||||
|
2021
Q4 | $2.95M | Buy |
|
|||||
|
2021
Q3 | $2.9M | Sell |
|
|||||
|
2021
Q2 | $4.07M | Sell |
|
|||||
|
2021
Q1 | $7.88M | Buy |
|
|||||
|
2020
Q4 | $3.69M | Sell |
|
|||||
|
2020
Q3 | $2.44M | Buy |
|
|||||
|
2020
Q2 | $1.75M | Buy |
|
|||||
|
2020
Q1 | $497K | Buy |
|
|||||
|
2019
Q4 | $815K | Buy |
|
|||||
|
2019
Q3 | $238K | Buy |
|
|||||
|
2019
Q2 | $171K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $201K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $174K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $5.78M | Buy |
|